PsychoGenics is the only CNS-focused contract research organization (CRO) of scale. We design and execute preclinical drug discovery and early development programs that leverage proprietary animal models and extensive capabilities in our AAALAC-accredited facility. Having cultivated lasting relationships with hundreds of repeat clients and drug discovery partners, we pride ourselves on the ability to tailor studies to specific client needs.
With comprehensive translational services that deliver on your needs, we’re dedicated to driving your progress so you can discover the next generation of breakthrough CNS therapies.
Your Preclinical Partner
When you work with PsychoGenics, you gain a true partner with the utmost expertise. We operate as your research arm, creating bespoke solutions for your unique challenges.
20+
years of experience
400+
client relationships with >70% of clients returning
20%+
industry thought leaders with a Ph.D.
30+
disease models
